BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 37239435)

  • 41. Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.
    Puneet ; Kazmi HR; Kumari S; Tiwari S; Khanna A; Narayan G
    Pathol Oncol Res; 2018 Oct; 24(4):757-770. PubMed ID: 29552712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
    Su Y; Shetty A; Jiang F
    Thorac Cancer; 2020 Aug; 11(8):2112-2124. PubMed ID: 32500672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
    Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y
    Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulatory Mechanism of MicroRNA Expression in Cancer.
    Ali Syeda Z; Langden SSS; Munkhzul C; Lee M; Song SJ
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcription.
    Hulf T; Sibbritt T; Wiklund ED; Bert S; Strbenac D; Statham AL; Robinson MD; Clark SJ
    BMC Genomics; 2011 Jan; 12():54. PubMed ID: 21255435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of DNA Methylation and DNA Methyltransferases in Cancer.
    Weisenberger DJ; Lakshminarasimhan R; Liang G
    Adv Exp Med Biol; 2022; 1389():317-348. PubMed ID: 36350516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions between m6A modification and miRNAs in malignant tumors.
    Han X; Guo J; Fan Z
    Cell Death Dis; 2021 Jun; 12(6):598. PubMed ID: 34108450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interplay between the miRNome and the epigenetic machinery: Implications in health and disease.
    Poddar S; Kesharwani D; Datta M
    J Cell Physiol; 2017 Nov; 232(11):2938-2945. PubMed ID: 28112397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNA methylation and cancer.
    Kulis M; Esteller M
    Adv Genet; 2010; 70():27-56. PubMed ID: 20920744
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of expression of microRNAs by DNA methylation in lung cancer.
    Singh DK; Bose S; Kumar S
    Biomarkers; 2016 Nov; 21(7):589-99. PubMed ID: 27122255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional complementation between transcriptional methylation regulation and post-transcriptional microRNA regulation in the human genome.
    Su Z; Xia J; Zhao Z
    BMC Genomics; 2011 Dec; 12 Suppl 5(Suppl 5):S15. PubMed ID: 22369656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co-localized genomic regulation of miRNA and mRNA via DNA methylation affects survival in multiple tumor types.
    Doecke JD; Wang Y; Baggerly K
    Cancer Genet; 2016 Oct; 209(10):463-473. PubMed ID: 27810075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic modifications and miRNAs determine the transition of somatic cells into somatic embryos.
    Ramakrishnan M; Zhou M; Ceasar SA; Ali DJ; Maharajan T; Vinod KK; Sharma A; Ahmad Z; Wei Q
    Plant Cell Rep; 2023 Dec; 42(12):1845-1873. PubMed ID: 37792027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA methylation-regulated microRNA pathways in ovarian serous cystadenocarcinoma: A meta-analysis.
    Agustriawan D; Huang CH; Sheu JJ; Lee SC; Tsai JJP; Kurubanjerdjit N; Ng KL
    Comput Biol Chem; 2016 Dec; 65():154-164. PubMed ID: 27746113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA methylation aberrancies as a guide for surveillance and treatment of human cancers.
    Liang G; Weisenberger DJ
    Epigenetics; 2017 Jun; 12(6):416-432. PubMed ID: 28358281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma.
    Paczkowska J; Janiszewska J; Bein J; Schneider M; Bednarek K; Ustaszewski A; Hartmann S; Hansmann ML; Giefing M
    Cells; 2020 Oct; 9(10):. PubMed ID: 33066457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disruption of CTCF at the miR-125b1 locus in gynecological cancers.
    Soto-Reyes E; González-Barrios R; Cisneros-Soberanis F; Herrera-Goepfert R; Pérez V; Cantú D; Prada D; Castro C; Recillas-Targa F; Herrera LA
    BMC Cancer; 2012 Jan; 12():40. PubMed ID: 22277129
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA Methylation in Colorectal Cancer.
    Kaur S; Lotsari-Salomaa JE; Seppänen-Kaijansinkko R; Peltomäki P
    Adv Exp Med Biol; 2016; 937():109-22. PubMed ID: 27573897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer.
    Vrba L; Muñoz-Rodríguez JL; Stampfer MR; Futscher BW
    PLoS One; 2013; 8(1):e54398. PubMed ID: 23342147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. microRNAs: Epigenetic players in cancer and aging.
    Iswariya GT; Paital B; Padma PR; Nirmaladevi R
    Front Biosci (Schol Ed); 2019 Mar; 11(1):29-55. PubMed ID: 30844735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.